Status:
COMPLETED
Helicobacter Pylori 23S rRNA/gyrA Gene Mutation Detection Kit (Fluorescence PCR Fusion Curve Method)
Lead Sponsor:
Nanjing First Hospital, Nanjing Medical University
Conditions:
Helicobacter Pylori Infection
Helicobacter Pylori gyrA Levofloxacin Resistance Mutation
Eligibility:
All Genders
18-70 years
Brief Summary
The purpose of this study was to evaluate the detection ability of Helicobacter pylori 23S rRNA/gyrA gene mutation detection kit (fluorescent PCR fusion curve method) for Helicobacter pylori gene muta...
Detailed Description
After being informed about the study and potential risks, all patients giving written informed consent will undergo a 1-week screening period to determine eligibility for study entry. At week 0, patie...
Eligibility Criteria
Inclusion
- 1\. patients with Helicobacter pylori infection who need gastroscopy; 2. patients with positive Helicobacter pylori culture in gastric mucosa 3. Helicobacter pylori negative patients
Exclusion
- Patients with insufficient fecal samples collected 2.Patients with contraindication of gastroscopic biopsy
Key Trial Info
Start Date :
August 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2023
Estimated Enrollment :
1176 Patients enrolled
Trial Details
Trial ID
NCT05410652
Start Date
August 1 2022
End Date
October 1 2023
Last Update
January 30 2024
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanjing First Hospital, Nanjing Medical University
Nanjing, Jiangsu, China, 210000
2
Jiangsu Taizhou People's Hospital
Taizhou, Jiangsu, China, 225300
3
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China, 330000
4
The First Affiliated Hospital of Zhejiang Chinese Medical University
Hangzhou, Zhejiang, China, 310003